NAD+ 500mg — research product

SKU.NAD

RESEARCH.OVERVIEW

NAD+ is a small molecule the body makes and uses in every cell. It helps turn food into energy, and it is needed by several families of enzymes — including the sirtuins tied to aging research. Most cellular NAD+ sits in the mitochondria; the body makes new NAD+ from tryptophan and by recycling it through NMN and NR. Older or stressed tissues carry measurably less NAD+ than younger, healthier ones — a well-documented finding, and the reason NAD+ research took off.

01.Details: Strength: 500mg. Form: lyophilized research material. Testing: third-party tested every batch. Documentation: COA for every batch.
02.Handling: Keep lyophilized research material sealed, protected from light, and handled with standard laboratory controls. Follow internal SOPs for storage, reconstitution, labeling and disposal.
03.Regulation: No FDA-approved NAD+ drug product exists for any indication. Intravenous NAD+ is compounded under Section 503A and is not FDA-approved; nicotinamide mononucleotide was removed from the dietary-supplement market on October 11, 2022.
04.Molecule: NAD+, also indexed as oxidized nicotinamide adenine dinucleotide, is a dinucleotide coenzyme of adenine and nicotinamide nucleotide units joined by pyrophosphate. Reference records identify it as C21H27N7O14P2, molecular weight 663.43 g/mol, CAS 53-84-9, PubChem CID 5893.
05.Testing: Every batch is independently tested and ships with its own certificate (mass spec, HPLC purity). Use the certificate to confirm identity and purity before work begins.
06.Resources: PubChemPubMedWikipediaResearch library →